Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Numbing drug may speed up gallbladder surgery recovery

NCT ID NCT02085902

Symptom relief Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether ropivacaine, a numbing medicine, can reduce pain and nausea after laparoscopic gallbladder removal. The goal was to help patients recover faster and go home the same day. 120 adults scheduled for surgery took part. The main focus was on how long it took for patients to be ready for discharge.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ropivacaine
What this could lead to
If it works, this could make same-day gallbladder surgery more common by reducing pain and nausea.
What could go wrong
This is a small, completed Phase 4 study. Ropivacaine is already used, but its benefit for same-day discharge is not proven. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

120 people

The number who actually took part.

Start date

Mar 2014

Finished

May 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Programmed Cholecystectomy * Laparoscopy * Man and woman * ≥ 18 * ASA 1 or 2 * Not living alone * Patient receiving social security coverage * Signature of Informed Consent Form Exclusion Criteria: * Cholecystectomy emergency * Patient minor * Pregnant woman (pregnancy test) or during breastfeeding * Conversion to laparotomy * Patient anticoagulant curative dose * Living alone * Patient addict * Peptic Ulcer * Refusal to enter the protocol * Chronic requiring analgesics long-term * Immunosuppression * Long-term Treatment with corticosteroids * Discovery intraoperative calculation in the bile duct * Contraindication to ropivacaine (see cons-indications to ropivacaine) * Hypersensitivity to study treatment or concomitant medications anesthesia * Cardiac or unbalanced epileptic patients (due to the risk of cardiovascular and neurological local anesthetics) * Patients ASA ≥ 3 * Patient \<50 kg

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cholecystectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cholecystectomy Laparoscopy

Contacts and locations

Locations

  • Centre hospitalier départemental Vendée

    La Roche-sur-Yon, 85925, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.